Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats.
Glycyrrhizin was found to inhibit prostaglandin E2 production by activated rat peritoneal macrophages. Preincubation of the cells with glycyrrhizin increases its inhibitory effectiveness. Glycyrrhetinic acid, the aglycone of glycyrrhizin, at a dose of 100 microgram per ml also inhibited prostaglandin E2 production, but the inhibition was considered to be attributable to a toxic effect on the cells since more than 30% of the cells were detached from the dish during the 8 hr incubation period. In contrast, glycyrrhizin did not detach the cells from the dish at doses up to 3 mg per ml. Release of [3H]arachidonic acid from prelabeled cells was also inhibited by glycyrrhizin. It is likely that anti-inflammatory activity of glycyrrhizin depends at least in part on its inhibitory effect of the production of prostaglandin E2.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001202:Ascitic Fluid / Q000378:metabolism*; D015232:Dinoprostone; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D019695:Glycyrrhizic Acid; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D011458:Prostaglandins E / Q000096:biosynthesis*; D051381:Rats
D001095:Arachidonic Acids; D011458:Prostaglandins E; D016718:Arachidonic Acid; D019695:Glycyrrhizic Acid; D015232:Dinoprostone; D006034:Glycyrrhetinic Acid